Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ginseng Guben Oral Liquid is a Traditional Chinese Medicine (TCM) formulation developed and studied by The Second Hospital, Cheeloo College of Medicine, Shandong University, specifically for the management of postoperative fatigue syndrome (POFS). The formula is derived from the classic "Ginseng Guben" prescription, which typically incorporates a blend of medicinal herbs including *Panax ginseng*, *Rehmannia glutinosa*, *Asparagus cochinchinensis*, and *Ophiopogon japonicus*. It is designed to tonify Qi and Yin, thereby addressing the physical exhaustion and physiological imbalances that occur following major surgical procedures. Pharmacologically, the liquid is believed to exert its effects by modulating the immune system, reducing the levels of pro-inflammatory cytokines such as Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-alpha), and enhancing antioxidant capacity to accelerate patient recovery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ginseng Guben Oral Liquid.